Becton Dickinson & Co (BDX)
237.29
+2.29
(+0.97%)
USD |
NYSE |
May 15, 16:00
237.23
-0.06
(-0.03%)
Pre-Market: 20:00
Becton Dickinson Free Cash Flow: 3.026B for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | 3.026B |
December 31, 2023 | 2.648B |
September 30, 2023 | 2.115B |
June 30, 2023 | 1.741B |
March 31, 2023 | 1.143B |
December 31, 2022 | 1.362B |
September 30, 2022 | 1.661B |
June 30, 2022 | 1.504B |
March 31, 2022 | 1.945B |
December 31, 2021 | 2.658B |
September 30, 2021 | 3.454B |
June 30, 2021 | 4.263B |
March 31, 2021 | 4.191B |
December 31, 2020 | 3.517B |
September 30, 2020 | 2.77B |
June 30, 2020 | 2.474B |
March 31, 2020 | 2.51B |
December 31, 2019 | 2.834B |
September 30, 2019 | 2.373B |
June 30, 2019 | 2.359B |
March 31, 2019 | 2.008B |
December 31, 2018 | 1.906B |
September 30, 2018 | 1.97B |
June 30, 2018 | 1.837B |
March 31, 2018 | 1.682B |
Date | Value |
---|---|
December 31, 2017 | 1.762B |
September 30, 2017 | 1.823B |
June 30, 2017 | 1.373B |
March 31, 2017 | 1.872B |
December 31, 2016 | 1.741B |
September 30, 2016 | 1.866B |
June 30, 2016 | 1.944B |
March 31, 2016 | 1.65B |
December 31, 2015 | 1.29B |
September 30, 2015 | 1.133B |
June 30, 2015 | 903.00M |
March 31, 2015 | 814.00M |
December 31, 2014 | 1.026B |
September 30, 2014 | 1.091B |
June 30, 2014 | 1.51B |
March 31, 2014 | 1.44B |
December 31, 2013 | 1.229B |
September 30, 2013 | 1.131B |
June 30, 2013 | 831.18M |
March 31, 2013 | 1.055B |
December 31, 2012 | 1.148B |
September 30, 2012 | 1.209B |
June 30, 2012 | 1.145B |
March 31, 2012 | 1.003B |
December 31, 2011 | 948.04M |
Free Cash Flow Range, Past 5 Years
1.143B
Minimum
Mar 2023
4.263B
Maximum
Jun 2021
2.527B
Average
2.492B
Median
Free Cash Flow Benchmarks
AngioDynamics Inc | -23.46M |
West Pharmaceutical Services Inc | 386.10M |
Abbott Laboratories | 4.923B |
Intuitive Surgical Inc | 595.80M |
Merit Medical Systems Inc | 130.63M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 515.00M |
Cash from Investing (Quarterly) | -1.056B |
Cash from Financing (Quarterly) | 1.705B |
Free Cash Flow Per Share (Quarterly) | 1.312 |
Free Cash Flow to Equity (Quarterly) | -1.52B |
Free Cash Flow to Firm (Quarterly) | 464.99M |
Free Cash Flow Yield | 4.38% |